Patients recovering from coronavirus infections have increased rates of neurological and psychological problems, according to an extensive observational study released Thursday.
Researchers at the University of Oxford combed over one million patient files and found that two years after infection, patients who recovered from COVID-19 had more psychosis, dementia, and We found that the risk of “brain fog” is high. Other respiratory diseases.
Some symptoms initially increased, but then leveled off. Anxiety and depression declined to rates similar to other respiratory illnesses after 2 months.
But in the case of Brain Fog, for example, adults aged 18 to 64 who recovered from COVID-19 suffered 16% higher rates than patients with other respiratory diseases. This difference was more pronounced in people over the age of 65, who are at higher risk for psychosis and dementia.
Data from patients, mostly in the United States, indicate that minors are also affected. A child who survived COVID-19 was twice as likely to suffer from epilepsy or seizures, and he was three times more likely to develop a psychotic disorder, compared to a child who recovered from a respiratory illness, but that The absolute risk of the condition remains low.
The study, published in The Lancet Psychiatry, showed that even the milder Omicron variant of the currently prevalent coronavirus poses similar long-term risks.
Maxim Take, one of the study authors, noted that the study only included patients who were in poor health and diagnosed with COVID-19, underestimating those with only mild symptoms. However, the same is true for comparison groups of patients who have recovered from other respiratory diseases.
The study is “to reveal what COVID as a virus does to you specifically, and what other viruses that affect the same parts of your body in a similar way generally do.” “The study was designed to identify the biological mechanisms by which the virus increases the risk of psychological and neurological disorders,” said lead author Paul Harrison. He added that it was nothing.
The paper supports growing evidence of the long-lasting damage caused by the coronavirus. The issue has raised concerns for governments, which are spending funds to research and treat a range of symptoms informally known as “long COVID,” a label that includes both neurological problems and fatigue and shortness of breath. I’m here.
The Institute for Health Metrics and Evaluation estimates that 3.7% of COVID-19 patients develop post-COVID-19 symptoms, said Janet Diaz, WHO’s director of the topic. . Speaking at a conference on Wednesday, she said the average severity of post-COVID conditions is comparable to what patients with severe neck pain, Crohn’s disease, or the long-term consequences of traumatic brain injury experience. I said there is.
This article is Politico Pro
POLITICO A one-stop-shop solution for policy makers that combines the depth of journalism with the power of technology
Exclusive breaking scoops and insights
Customized Policy Intelligence Platform
high-level public relations network
.
